Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-04

Clinical Trial Update: A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating ZL-82 tablets for atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZL-82 tablets

Snippet

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING